wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38198739-544B1A15-BFEB-450E-8098-7B339AA061B9
Q38198739-544B1A15-BFEB-450E-8098-7B339AA061B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38198739-544B1A15-BFEB-450E-8098-7B339AA061B9
Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence.
P2860
Q38198739-544B1A15-BFEB-450E-8098-7B339AA061B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38198739-544B1A15-BFEB-450E-8098-7B339AA061B9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5768f6aceb2044747650dcc1aa551c7848b325b8
P2860
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.